Symbols / RXST Stock $5.63 +1.44% RxSight, Inc.

Healthcare • Medical Devices • United States • NGM
RXST (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Dr. Ronald M. Kurtz M.D.
Exch · Country NGM · United States
Market Cap 233.06M
Enterprise Value 26.01M
Income -46.64M
Sales 127.48M
FCF (ttm) -969.25K
Book/sh 6.68
Cash/sh 5.26
Employees 461
Insider 10d —
IPO Jul 30, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -9.23
PEG —
P/S 1.83
P/B 0.84
P/C —
EV/EBITDA -0.50
EV/Sales 0.20
Quick Ratio 8.78
Current Ratio 10.20
Debt/Eq 4.05
LT Debt/Eq —
EPS (ttm) -1.13
EPS next Y -0.61
EPS Growth —
Revenue Growth -18.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-06
ROA -11.21%
ROE -17.06%
ROIC —
Gross Margin 77.02%
Oper. Margin -57.71%
Profit Margin -36.59%
Shs Outstand 41.40M
Shs Float 37.05M
Insider Own 5.66%
Instit Own 90.48%
Short Float 14.21%
Short Ratio 7.56
Short Interest 5.57M
52W High 16.74
vs 52W High -66.37%
52W Low 5.30
vs 52W Low 6.23%
Beta 1.24
Impl. Vol. 25.00%
Rel Volume 0.55
Avg Volume 758.25K
Volume 419.74K
Target (mean) $8.79
Tgt Median $8.00
Tgt Low $7.50
Tgt High $11.00
# Analysts 7
Recom Hold
Prev Close $5.55
Price $5.63
Change 1.44%
About

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$8.79
Mean price target
2. Current target
$5.63
Latest analyst target
3. DCF / Fair value
$-0.42
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.63
Low
$7.50
High
$11.00
Mean
$8.79

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-07 main Wells Fargo Equal-Weight → Equal-Weight $9
2026-05-07 main Needham Buy → Buy $11
2026-03-09 main Stifel Hold → Hold $9
2026-02-26 main UBS Neutral → Neutral $9
2026-02-26 main Piper Sandler Neutral → Neutral $10
2026-02-26 reit Needham Buy → Buy $13
2026-01-20 main Piper Sandler Neutral → Neutral $11
2025-12-02 main Morgan Stanley Equal-Weight → Equal-Weight $10
2025-11-06 main JP Morgan Underweight → Underweight $9
2025-11-06 main Wells Fargo Equal-Weight → Equal-Weight $10
2025-11-06 main Needham Buy → Buy $12
2025-08-08 main UBS Neutral → Neutral $8
2025-08-08 main Stifel Hold → Hold $8
2025-08-08 main Needham Buy → Buy $11
2025-07-15 down Morgan Stanley Overweight → Equal-Weight $9
2025-07-10 down Jefferies Buy → Hold $9
2025-07-09 main B of A Securities Underperform → Underperform $9
2025-07-09 main Piper Sandler Neutral → Neutral $10
2025-07-09 main Stifel Hold → Hold $9
2025-07-09 down Wells Fargo Overweight → Equal-Weight $9
News
RSS: Latest RXST news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-17 GOLDSHLEGER ILYA Chief Operating Officer — 12,489 $4.13 $51,580
2026-02-27 GAINES SCOTT Officer — 6,261 — —
2026-02-27 WILTERDING MARK Chief Financial Officer — 20,441 — —
2025-09-25 GOLDSHLEGER ILYA President — 23,445 $4.13 $99,998
2025-07-31 COHEN RAYMOND W Director — 35,668 $0.00 $0
2025-06-03 PALMISANO ROBERT J Director — 10,752 $0.00 $0
2025-06-03 ANDREWS JULIE Director — 10,752 $0.00 $0
2025-06-03 TAMMENOMS BAKKER JULIET Director — 10,752 $0.00 $0
2025-06-03 LINK WILLIAM J Director — 10,752 $0.00 $0
2025-06-03 MANIAR SHWETA SINGH Director — 10,752 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
134.48
-3.89%
139.93
+57.09%
89.08
+81.77%
49.01
Operating Revenue
134.48
-3.89%
139.93
+57.09%
89.08
+81.77%
49.01
Cost Of Revenue
31.47
-23.21%
40.98
+16.06%
35.31
+27.59%
27.68
Reconciled Cost Of Revenue
31.47
-23.21%
40.98
+16.06%
35.31
+27.59%
27.68
Gross Profit
103.01
+4.11%
98.94
+84.03%
53.77
+152.09%
21.33
Operating Expense
151.20
+11.34%
135.80
+30.77%
103.85
+22.69%
84.65
Research And Development
38.55
+12.17%
34.37
+18.30%
29.05
+11.82%
25.98
Selling General And Administration
112.65
+11.06%
101.43
+35.61%
74.80
+27.50%
58.66
Total Expenses
182.67
+3.33%
176.78
+27.04%
139.16
+23.89%
112.32
Operating Income
-48.19
-30.75%
-36.86
+26.41%
-50.09
+20.90%
-63.32
Total Operating Income As Reported
-48.19
-30.75%
-36.86
+26.41%
-50.09
+20.90%
-63.32
EBITDA
-35.59
-49.49%
-23.81
+42.21%
-41.20
+28.69%
-57.78
Normalized EBITDA
-35.59
-49.49%
-23.81
+39.62%
-39.43
+31.75%
-57.78
Reconciled Depreciation
3.27
-8.64%
3.58
-12.33%
4.08
+1.39%
4.02
EBIT
-38.86
-41.90%
-27.38
+39.52%
-45.28
+26.73%
-61.80
Total Unusual Items
0.00
0.00
+100.00%
-1.77
0.00
Total Unusual Items Excluding Goodwill
0.00
0.00
+100.00%
-1.77
0.00
Special Income Charges
0.00
0.00
+100.00%
-1.77
0.00
Other Special Charges
—
—
1.77
—
Net Income
-38.94
-41.85%
-27.45
+43.52%
-48.61
+27.19%
-66.76
Pretax Income
-38.88
-41.86%
-27.41
+43.60%
-48.59
+27.21%
-66.75
Net Non Operating Interest Income Expense
9.31
-1.48%
9.45
+189.44%
3.27
+195.25%
-3.43
Interest Expense Non Operating
0.02
-9.52%
0.02
-99.37%
3.31
-33.12%
4.95
Net Interest Income
9.31
-1.48%
9.45
+189.44%
3.27
+195.25%
-3.43
Interest Expense
0.02
-9.52%
0.02
-99.37%
3.31
-33.12%
4.95
Interest Income Non Operating
9.33
-1.50%
9.47
+44.11%
6.57
+333.36%
1.52
Interest Income
9.33
-1.50%
9.47
+44.11%
6.57
+333.36%
1.52
Other Income Expense
—
—
-1.77
—
Gain On Sale Of Security
—
—
—
—
Tax Provision
0.07
+32.00%
0.05
+150.00%
0.02
+122.22%
0.01
Tax Rate For Calcs
0.00
+0.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-38.94
-41.85%
-27.45
+43.52%
-48.61
+27.19%
-66.76
Net Income From Continuing Operation Net Minority Interest
-38.94
-41.85%
-27.45
+43.52%
-48.61
+27.19%
-66.76
Net Income From Continuing And Discontinued Operation
-38.94
-41.85%
-27.45
+43.52%
-48.61
+27.19%
-66.76
Net Income Continuous Operations
-38.94
-41.85%
-27.45
+43.52%
-48.61
+27.19%
-66.76
Normalized Income
-38.94
-41.85%
-27.45
+41.38%
-46.84
+29.84%
-66.76
Net Income Common Stockholders
-38.94
-41.85%
-27.45
+43.52%
-48.61
+27.19%
-66.76
Otherunder Preferred Stock Dividend
—
—
—
—
Diluted EPS
—
-0.71
+49.65%
-1.41
+41.49%
-2.41
Basic EPS
—
-0.71
+49.65%
-1.41
+41.49%
-2.41
Basic Average Shares
—
38.87
+12.81%
34.46
+24.56%
27.66
Diluted Average Shares
—
38.87
+12.81%
34.46
+24.56%
27.66
Diluted NI Availto Com Stockholders
-38.94
-41.85%
-27.45
+43.52%
-48.61
+27.19%
-66.76
Gain On Sale Of PPE
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
311.81
-2.12%
318.56
+74.51%
182.55
+21.57%
150.16
Current Assets
287.46
-2.17%
293.82
+74.47%
168.41
+25.16%
134.56
Cash Cash Equivalents And Short Term Investments
228.13
-3.83%
237.22
+86.52%
127.18
+20.21%
105.80
Cash And Cash Equivalents
19.95
+19.41%
16.71
+72.37%
9.69
-18.10%
11.83
Other Short Term Investments
208.18
-5.60%
220.52
+87.69%
117.49
+25.03%
93.97
Receivables
23.38
-22.19%
30.05
+48.17%
20.28
+85.11%
10.96
Accounts Receivable
23.38
-22.19%
30.05
+48.17%
20.28
+85.11%
10.96
Inventory
31.56
+43.39%
22.01
+26.34%
17.42
+17.43%
14.84
Raw Materials
8.34
+17.33%
7.11
+25.16%
5.68
-12.53%
6.49
Work In Process
3.56
+2.04%
3.48
-15.95%
4.14
+61.47%
2.57
Finished Goods
21.64
+79.86%
12.03
+48.65%
8.09
+26.28%
6.41
Prepaid Assets
—
—
—
—
Other Current Assets
4.39
-3.35%
4.54
+28.90%
3.52
+18.94%
2.96
Total Non Current Assets
24.36
-1.56%
24.74
+74.93%
14.14
-9.39%
15.61
Net PPE
23.02
-2.60%
23.63
+77.87%
13.29
-5.65%
14.08
Gross PPE
49.58
+1.07%
49.06
+36.34%
35.98
+5.90%
33.98
Accumulated Depreciation
-26.57
-4.48%
-25.43
-12.03%
-22.70
-14.07%
-19.90
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
20.99
+7.96%
19.45
+11.18%
17.49
+13.42%
15.42
Construction In Progress
1.72
+11.47%
1.54
-33.92%
2.33
+75.43%
1.33
Other Properties
11.71
-15.33%
13.82
+200.20%
4.61
-23.53%
6.02
Leases
15.17
+6.46%
14.25
+23.31%
11.55
+3.10%
11.21
Other Non Current Assets
1.34
+20.72%
1.11
+29.37%
0.86
-43.85%
1.53
Total Liabilities Net Minority Interest
36.13
-3.20%
37.33
+68.22%
22.19
-63.18%
60.26
Current Liabilities
26.25
+1.46%
25.88
+23.79%
20.90
+21.27%
17.24
Payables And Accrued Expenses
5.30
+16.55%
4.54
+17.63%
3.86
+26.66%
3.05
Payables
5.30
+16.55%
4.54
+17.63%
3.86
+48.86%
2.60
Accounts Payable
5.30
+16.55%
4.54
+17.63%
3.86
+48.86%
2.60
Current Accrued Expenses
—
—
0.00
-100.00%
0.46
Pensionand Other Post Retirement Benefit Plans Current
10.49
-27.46%
14.46
+35.94%
10.64
+24.60%
8.54
Current Debt And Capital Lease Obligation
1.16
+19.30%
0.97
-45.92%
1.80
-8.58%
1.97
Current Capital Lease Obligation
1.16
+19.30%
0.97
-45.92%
1.80
-8.58%
1.97
Current Deferred Liabilities
3.60
+15.76%
3.11
+52.08%
2.04
+51.71%
1.35
Current Deferred Revenue
3.60
+15.76%
3.11
+52.08%
2.04
+51.71%
1.35
Other Current Liabilities
5.71
+104.63%
2.79
+9.03%
2.56
+9.65%
2.33
Total Non Current Liabilities Net Minority Interest
9.88
-13.72%
11.45
+790.97%
1.28
-97.01%
43.02
Long Term Debt And Capital Lease Obligation
9.88
-12.75%
11.32
+834.93%
1.21
-97.19%
43.02
Long Term Debt
—
—
—
40.17
Long Term Capital Lease Obligation
9.88
-12.75%
11.32
+834.93%
1.21
-57.60%
2.86
Other Non Current Liabilities
—
0.13
+71.62%
0.07
—
Stockholders Equity
275.68
-1.98%
281.24
+75.38%
160.36
+78.37%
89.90
Common Stock Equity
275.68
-1.98%
281.24
+75.38%
160.36
+78.37%
89.90
Capital Stock
0.04
+2.50%
0.04
+11.11%
0.04
+28.57%
0.03
Common Stock
0.04
+2.50%
0.04
+11.11%
0.04
+28.57%
0.03
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
41.24
+2.01%
40.43
+11.87%
36.14
+27.84%
28.27
Ordinary Shares Number
41.24
+2.01%
40.43
+11.87%
36.14
+27.84%
28.27
Additional Paid In Capital
936.63
+3.71%
903.13
+19.62%
754.97
+18.71%
636.00
Retained Earnings
-661.04
-6.26%
-622.10
-4.62%
-594.64
-8.90%
-546.03
Gains Losses Not Affecting Retained Earnings
0.05
-68.07%
0.17
+3420.00%
-0.01
+94.74%
-0.10
Other Equity Adjustments
0.05
-68.07%
0.17
+3420.00%
-0.01
+94.74%
-0.10
Total Equity Gross Minority Interest
275.68
-1.98%
281.24
+75.38%
160.36
+78.37%
89.90
Total Capitalization
275.68
-1.98%
281.24
+75.38%
160.36
+23.29%
130.07
Working Capital
261.21
-2.52%
267.95
+81.65%
147.50
+25.73%
117.32
Invested Capital
275.68
-1.98%
281.24
+75.38%
160.36
+23.29%
130.07
Total Debt
11.04
-10.21%
12.30
+308.23%
3.01
-93.31%
44.99
Net Debt
—
—
—
28.34
Capital Lease Obligations
11.04
-10.21%
12.30
+308.23%
3.01
-37.59%
4.83
Net Tangible Assets
275.68
-1.98%
281.24
+75.38%
160.36
+78.37%
89.90
Tangible Book Value
275.68
-1.98%
281.24
+75.38%
160.36
+78.37%
89.90
Derivative Product Liabilities
—
—
—
—
Interest Payable
—
—
0.00
-100.00%
0.46
Inventories Adjustments Allowances
-1.97
-221.70%
-0.61
-23.59%
-0.50
+21.77%
-0.63
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-15.51
+8.47%
-16.95
+59.26%
-41.59
+29.32%
-58.85
Cash Flow From Continuing Operating Activities
-15.51
+8.47%
-16.95
+59.26%
-41.59
+29.32%
-58.85
Net Income From Continuing Operations
-38.94
-41.85%
-27.45
+43.52%
-48.61
+27.19%
-66.76
Depreciation Amortization Depletion
3.27
-8.64%
3.58
-12.33%
4.08
+1.39%
4.02
Depreciation
3.27
-8.64%
3.58
-12.33%
4.08
+1.39%
4.02
Depreciation And Amortization
3.27
-8.64%
3.58
-12.33%
4.08
+1.39%
4.02
Other Non Cash Items
—
—
0.29
-48.01%
0.55
Stock Based Compensation
31.61
+28.32%
24.64
+56.45%
15.75
+38.16%
11.40
Provisionand Write Offof Assets
1.96
+348.40%
0.44
+167.07%
0.16
-78.19%
0.75
Operating Gains Losses
—
—
1.77
—
Gain Loss On Investment Securities
—
—
—
—
Gain Loss On Sale Of PPE
—
—
—
—
Change In Working Capital
-4.89
+46.61%
-9.16
-2.86%
-8.91
-20.17%
-7.41
Change In Receivables
6.66
+167.89%
-9.80
-5.13%
-9.32
-53.02%
-6.09
Changes In Account Receivables
6.66
+167.89%
-9.80
-5.13%
-9.32
-53.02%
-6.09
Change In Inventory
-11.48
-129.96%
-4.99
-81.63%
-2.75
+63.61%
-7.55
Change In Prepaid Assets
1.18
+200.17%
-1.18
-197.48%
-0.40
-150.32%
0.79
Change In Payables And Accrued Expense
-1.25
-118.31%
6.82
+91.22%
3.56
-34.58%
5.45
Change In Accrued Expense
-1.88
-131.95%
5.87
+153.63%
2.31
-51.92%
4.81
Change In Payable
0.63
-33.72%
0.95
-24.32%
1.25
+96.85%
0.64
Change In Account Payable
0.63
-33.72%
0.95
-24.32%
1.25
+96.85%
0.64
Investing Cash Flow
16.89
+117.01%
-99.31
-348.78%
-22.13
-155.39%
39.95
Cash Flow From Continuing Investing Activities
16.89
+117.01%
-99.31
-348.78%
-22.13
-155.39%
39.95
Net PPE Purchase And Sale
-3.83
+29.60%
-5.44
-13.00%
-4.81
-101.17%
-2.39
Purchase Of PPE
-3.83
+29.60%
-5.44
-13.00%
-4.81
-101.17%
-2.39
Sale Of PPE
—
—
—
—
Capital Expenditure
-3.83
+29.60%
-5.44
-13.00%
-4.81
-101.17%
-2.39
Net Investment Purchase And Sale
20.72
+122.07%
-93.87
-442.14%
-17.32
-140.89%
42.34
Purchase Of Investment
-239.28
+28.97%
-336.87
-23.71%
-272.31
-28.05%
-212.66
Sale Of Investment
260.00
+7.00%
243.00
-4.71%
255.00
+0.00%
255.00
Financing Cash Flow
1.86
-98.49%
123.32
+100.44%
61.52
+871.64%
6.33
Cash Flow From Continuing Financing Activities
1.86
-98.49%
123.32
+100.44%
61.52
+871.64%
6.33
Net Issuance Payments Of Debt
-0.03
+57.38%
-0.06
+99.85%
-40.15
-33084.30%
-0.12
Issuance Of Debt
0.00
0.00
-100.00%
20.00
0.00
Repayment Of Debt
-0.03
+57.38%
-0.06
+99.90%
-60.15
-49613.22%
-0.12
Long Term Debt Issuance
0.00
0.00
-100.00%
20.00
0.00
Long Term Debt Payments
-0.03
+57.38%
-0.06
+99.90%
-60.15
-49613.22%
-0.12
Net Long Term Debt Issuance
-0.03
+57.38%
-0.06
+99.85%
-40.15
-33084.30%
-0.12
Net Common Stock Issuance
3.95
-96.94%
128.92
+21.67%
105.96
+1253.56%
7.83
Proceeds From Stock Option Exercised
—
—
—
1.78
Net Other Financing Charges
-2.06
+62.75%
-5.54
-29.35%
-4.28
-211.27%
-1.38
Changes In Cash
3.24
-54.12%
7.06
+421.29%
-2.20
+82.51%
-12.57
Effect Of Exchange Rate Changes
0.00
+133.33%
-0.01
-250.00%
0.01
+166.67%
-0.01
Beginning Cash Position
17.46
+67.80%
10.40
-17.40%
12.60
-49.96%
25.17
End Cash Position
20.70
+18.58%
17.46
+67.80%
10.40
-17.40%
12.60
Free Cash Flow
-19.34
+13.60%
-22.39
+51.76%
-46.41
+24.22%
-61.24
Interest Paid Supplemental Data
0.00
0.00
-100.00%
3.46
-18.63%
4.26
Income Tax Paid Supplemental Data
0.06
+141.67%
0.02
+200.00%
0.01
+166.67%
0.00
Amortization Of Securities
-8.52
+5.12%
-8.98
-46.64%
-6.12
-335.73%
-1.41
Common Stock Issuance
3.95
-96.94%
128.92
+21.67%
105.96
+1253.56%
7.83
Issuance Of Capital Stock
3.95
-96.94%
128.92
+21.67%
105.96
+1253.56%
7.83
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category